Suri A - Search Results

1

Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells.

Seidel RD, Merazga Z, Thapa DR, Soriano J, Spaulding E, Vakkasoglu AS, Ruthardt P, Bautista W, Quayle SN, Kiener PA, Low S, Ross JF, Cemerski S, Suri A, Almo SC, Chaparro RJ. Seidel RD, et al. Among authors: suri a. Sci Rep. 2021 Sep 28;11(1):19220. doi: 10.1038/s41598-021-98716-z. Sci Rep. 2021. PMID: 34584159 Free PMC article.

2

CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies.

Quayle SN, Girgis N, Thapa DR, Merazga Z, Kemp MM, Histed A, Zhao F, Moreta M, Ruthardt P, Hulot S, Nelson A, Kraemer LD, Beal DR, Witt L, Ryabin J, Soriano J, Haydock M, Spaulding E, Ross JF, Kiener PA, Almo S, Chaparro R, Seidel R, Suri A, Cemerski S, Pienta KJ, Simcox ME. Quayle SN, et al. Among authors: suri a. Clin Cancer Res. 2020 Apr 15;26(8):1953-1964. doi: 10.1158/1078-0432.CCR-19-3354. Epub 2020 Jan 21. Clin Cancer Res. 2020. PMID: 31964784

3

IL-12 enhances CTL synapse formation and induces self-reactivity.

Markiewicz MA, Wise EL, Buchwald ZS, Cheney EE, Hansen TH, Suri A, Cemerski S, Allen PM, Shaw AS. Markiewicz MA, et al. Among authors: suri a. J Immunol. 2009 Feb 1;182(3):1351-61. doi: 10.4049/jimmunol.182.3.1351. J Immunol. 2009. PMID: 19155481 Free PMC article.

4

I-Ep-bound self-peptides: identification, characterization, and role in alloreactivity.

Felix NJ, Suri A, Walters JJ, Horvath S, Gross ML, Allen PM. Felix NJ, et al. Among authors: suri a. J Immunol. 2006 Jan 15;176(2):1062-71. doi: 10.4049/jimmunol.176.2.1062. J Immunol. 2006. PMID: 16393994

5

Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes.

Felix NJ, Donermeyer DL, Horvath S, Walters JJ, Gross ML, Suri A, Allen PM. Felix NJ, et al. Among authors: suri a. Nat Immunol. 2007 Apr;8(4):388-97. doi: 10.1038/ni1446. Epub 2007 Feb 25. Nat Immunol. 2007. PMID: 17322886

6

The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form.

Levisetti MG, Suri A, Petzold SJ, Unanue ER. Levisetti MG, et al. Among authors: suri a. J Immunol. 2007 May 15;178(10):6051-7. doi: 10.4049/jimmunol.178.10.6051. J Immunol. 2007. PMID: 17475829

7

IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.

Calderon B, Suri A, Pan XO, Mills JC, Unanue ER. Calderon B, et al. Among authors: suri a. J Immunol. 2008 Nov 15;181(10):6964-74. doi: 10.4049/jimmunol.181.10.6964. J Immunol. 2008. PMID: 18981116 Free PMC article.

8

First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules.

Suri A, Walters JJ, Rohrs HW, Gross ML, Unanue ER. Suri A, et al. J Immunol. 2008 Mar 15;180(6):3849-56. doi: 10.4049/jimmunol.180.6.3849. J Immunol. 2008. PMID: 18322192

9

In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket.

Suri A, Vidavsky I, van der Drift K, Kanagawa O, Gross ML, Unanue ER. Suri A, et al. J Immunol. 2002 Feb 1;168(3):1235-43. doi: 10.4049/jimmunol.168.3.1235. J Immunol. 2002. PMID: 11801660

10

CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms.

Ise W, Kohyama M, Nutsch KM, Lee HM, Suri A, Unanue ER, Murphy TL, Murphy KM. Ise W, et al. Among authors: suri a. Nat Immunol. 2010 Feb;11(2):129-35. doi: 10.1038/ni.1835. Epub 2009 Dec 27. Nat Immunol. 2010. PMID: 20037585 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters